Ketamine in Refractory Convulsive Status Epilepticus (KETASER01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02431663

Recruitment Status : Terminated (Futility)

First Posted : May 1, 2015

Last Update Posted : October 8, 2020

Sponsor:

Collaborators:

Ospedali Riuniti Ancona

IRCCS Azienda Ospedaliero-Universitaria di Bologna

University of Padova

Bambino Gesù Hospital and Research Institute

Catholic University of the Sacred Heart

IRCCS Burlo Garofolo

Azienda Ospedaliera Universitaria Integrata Verona

Nuovo Regina Margherita Hospital

Vittore Buzzi Children's Hospital

Information provided by (Responsible Party):

Anna Rosati, Meyer Children's Hospital

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Terminated
Actual Primary Completion Date :	March 31, 2020
Actual Study Completion Date :	March 31, 2020

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Rosati A, De Masi S, Guerrini R. Ketamine for Refractory Status Epilepticus: A Systematic Review. CNS Drugs. 2018 Nov;32(11):997-1009. doi: 10.1007/s40263-018-0569-6.

Rosati A, Ilvento L, L'Erario M, De Masi S, Biggeri A, Fabbro G, Bianchi R, Stoppa F, Fusco L, Pulitanò S, Battaglia D, Pettenazzo A, Sartori S, Biban P, Fontana E, Cesaroni E, Mora D, Costa P, Meleleo R, Vittorini R, Conio A, Wolfler A, Mastrangelo M, Mondardini MC, Franzoni E, McGreevy KS, Di Simone L, Pugi A, Mirabile L, Vigevano F, Guerrini R. Efficacy of ketamine in refractory convulsive status epilepticus in children: a protocol for a sequential design, multicentre, randomised, controlled, open-label, non-profit trial (KETASER01). BMJ Open. 2016 Jun 15;6(6):e011565. doi: 10.1136/bmjopen-2016-011565.

To Top